PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 4, 2013European Heart Journal Acute Cardiovascular Care101 citationsOpen Access

Impaired coronary microvascular reactivity in women with apical ballooning syndrome (Takotsubo/stress cardiomyopathy)

SPSandeep M. PatelALAmir LermanRLRyan J. Lennon

Key Result

Women with prior apical ballooning syndrome demonstrated markedly impaired coronary microvascular reactivity to acetylcholine compared to a reference group (median blood flow increase 13.1% vs 103%).

Study Design

Type

Observational (n=221)

Structured PICO

Do patients with prior apical ballooning syndrome have impaired coronary microvascular reactivity compared to normal controls?

P
Population
10 female patients (median age 61) with prior apical ballooning syndrome who underwent coronary vasomotion testing, compared to a reference group of 211 women.
E
Exposure
Coronary vasomotion testing using intracoronary acetylcholine (10(-6)-10(-4) mol/l), nitroglycerin (200-300 mg), and adenosine (36-60 µg)
C
Comparator
Reference group of 211 women with normal microvascular responses to acetylcholine (mean age 60 years)
O
Outcome
Coronary epicardial and microvascular responses to intracoronary acetylcholine (% change in diameter and % change in blood flow)surrogate

Coronary microvascular dysfunction is highly prevalent in patients with prior apical ballooning syndrome, suggesting it may be a central feature of its pathophysiology.

Main Result

Absolute Event Rate: 13.1% vs 103%

Abstract

AIMS: The pathophysiology of apical ballooning syndrome (ABS) remains to be elucidated. The aim of this study was to evaluate the coronary vascular reactivity of patients who were previously diagnosed with ABS. METHODS AND RESULTS: A total of 228 cases of ABS were prospectively identified, and of these, 10 patients (median age 61 years (IQR 48-75); all females) who underwent coronary vasomotion testing were included in the study. Coronary epicardial and microvascular responses to intracoronary acetylcholine (ACH; % change in diameter and % change in blood flow at doses of 10(-6)-10(-4) mol/l), nitroglycerin (200-300 mg), and adenosine (36-60 µg) were evaluated. The median change in diameter with ACH was -9.3% (IQR -36.4, 3.2) with six patients (60%) demonstrating epicardial coronary constriction. The median increase in peak coronary blood flow in response to ACH was 13.1% (IQR -18.6, 55.0). This was markedly lower than the blood flow response seen in a reference group of 211 women from our laboratory (mean age 60 years) with normal microvascular responses to ACH: 103% (IQR 75, 149). Seven (70%) patients had 2.5), and 90% had at least one abnormal measure of microvascular vasomotion. CONCLUSION: The novel observation is that coronary microvascular dysfunction is highly prevalent in patients with ABS. Thus, chronically impaired coronary vascular reactivity, especially involving the microcirculation, may be a central feature of the pathophysiology of ABS.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Patel et al. (2013) conducted an observational in Apical ballooning syndrome (Takotsubo/stress cardiomyopathy) (n=221). Apical ballooning syndrome vs. Reference group of women with normal microvascular responses was evaluated on Increase in peak coronary blood flow in response to acetylcholine. Women with prior apical ballooning syndrome demonstrated markedly impaired coronary microvascular reactivity to acetylcholine compared to a reference group (median blood flow increase 13.1% vs 103%).

synapsesocial.com/papers/6a659985f7d63978b6e901a1https://doi.org/10.1177/2048872613475891
Ask AI
Helpful
Bookmark
Share
View Full Paper